Construction of a chromosome 17 transcriptome in serous ovarian cancer identifies differentially expressed genes
Wojnarowicz, P M, Breznan, A, Arcand, S L, Filali-Mouhim, A, Provencher, D M, Mes-Masson, A-M, Tonin, P N
Published in International journal of gynecological cancer (01.09.2008)
Published in International journal of gynecological cancer (01.09.2008)
Get full text
Journal Article
Chemosensitivity and radiosensitivity profiles of four new human epithelial ovarian cancer cell lines exhibiting genetic alterations in BRCA2, TGFβ-RII, KRAS2, TP53 and/or CDNK2A
SAMOUËLIAN, V, MAUGARD, C. M, JOLICOEUR, M, BERTRAND, R, ARCAND, S. L, TONIN, P. N, PROVENCHER, D. M, MES-MASSON, A.-M
Published in Cancer chemotherapy and pharmacology (01.12.2004)
Published in Cancer chemotherapy and pharmacology (01.12.2004)
Get full text
Journal Article
Gene expression microarray analysis and genome databases facilitate the characterization of a chromosome 22 derived homogenously staining region
Arcand, Suzanna L., Mes-Masson, Anne-Marie, Provencher, Diane, Hudson, Thomas J., Tonin, Patricia N.
Published in Molecular carcinogenesis (01.09.2004)
Published in Molecular carcinogenesis (01.09.2004)
Get full text
Journal Article
Global analysis of chromosome X gene expression in primary cultures of normal ovarian surface epithelial cells and epithelial ovarian cancer cell lines
Benoît, Marie-Hélène, Hudson, Thomas J, Maire, Georges, Squire, Jeremy A, Arcand, Suzanna L, Provencher, Diane, Mes-Masson, Anne-Marie, Tonin, Patricia N
Published in International journal of oncology (01.01.2007)
Published in International journal of oncology (01.01.2007)
Get full text
Journal Article
Chemosensitivity and radiosensitivity profiles of four new human epithelial ovarian cancer cell lines exhibiting genetic alterations in BRCA2, TGF?-RII, KRAS2, TP53 and/or CDNK2A
Samou lian, V., Maugard, C. M., Jolicoeur, M., Bertrand, R., Arcand, S. L., Tonin, P. N., Provencher, D. M., Mes-Masson, A.-M.
Published in Cancer chemotherapy and pharmacology (01.12.2004)
Published in Cancer chemotherapy and pharmacology (01.12.2004)
Get full text
Journal Article
Chemosensitivity and radiosensitivity profiles of four new human epithelial ovarian cancer cell lines exhibiting genetic alterations in BRCA2, TGFbeta-RII, KRAS2, TP53 and/or CDNK2A
Samouëlian, V, Maugard, C M, Jolicoeur, M, Bertrand, R, Arcand, S L, Tonin, P N, Provencher, D M, Mes-Masson, A-M
Published in Cancer chemotherapy and pharmacology (01.12.2004)
Get full text
Published in Cancer chemotherapy and pharmacology (01.12.2004)
Journal Article
Chemosensitivity and radiosensitivity profiles of four new human epithelial ovarian cancer cell lines exhibiting genetic alterations in BRCA2, TGFβ-RII, KRAS2, TP53 and/or CDNK2A
Samouëlian, V, Maugard, C M, Jolicoeur, M, Bertrand, R, Arcand, S L, Tonin, P N, Provencher, D M, A.-M. Mes-Masson
Published in Cancer chemotherapy and pharmacology (01.12.2004)
Published in Cancer chemotherapy and pharmacology (01.12.2004)
Get full text
Journal Article
Significant proportion of breast and/or ovarian cancer families of French Canadian descent harbor 1 of 5 BRCA1 and BRCA2 mutations
Oros, Kathleen K., Ghadirian, Parviz, Greenwood, Celia M.T, Perret, Chantal, Shen, Zhen, Paredes, Yosabeth, Arcand, Suzanna L., Mes‐Masson, Anne‐Marie, Narod, Steven A., Foulkes, William D., Provencher, Diane, Tonin, Patricia N.
Published in International journal of cancer (10.11.2004)
Published in International journal of cancer (10.11.2004)
Get full text
Journal Article